Global Bio Pharma Buffer Market Growth 2025-2031

Publication ID:

LPI03253240

Publication Date:

March 21, 2025

Pages:

124

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Bio Pharma Buffer market size is predicted to grow from US$ 1006 million in 2025 to US$ 1550 million in 2031; it is expected to grow at a CAGR of 7.5% from 2025 to 2031.
A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.
Most purification steps for downstream processing of biologics require buffers to equilibrate, condition, wash, elute, or concentrate the product. They are used in product isolation and purification steps to facilitate protein capture and polishing and also in the filtration process for the removal of viruses or depyrogenation. Aqueous solutions are also required for cleaning and disinfecting downstream processing equipment, such as chromatography matrices and membrane filtration systems. The main equipment involved in downstream processing with buffers includes mixers for buffer preparation, as well as equipment for purification, including packed-bed chromatography systems, fluidized beds, ultrafiltration and diafiltration membranes, microfiltration membranes, depth filtration cartridges, and virus-removal systems.
The key players are Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza, Bio-Rad, BD, GE, Healthcare, Promega Corporation, Hamilton Company, XZL BIO-TECHNOLOGY, SRL and so on. According to the revenue of these companies, we can know that the Bio Pharma Buffer industry is relative concentrated. Because the top 6 companies have more than 70% market share.
The 鈥淏io Pharma Buffer Industry Forecast鈥� looks at past sales and reviews total world Bio Pharma Buffer sales in 2024, providing a comprehensive analysis by region and market sector of projected Bio Pharma Buffer sales for 2025 through 2031. With Bio Pharma Buffer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bio Pharma Buffer industry.
This Insight Report provides a comprehensive analysis of the global Bio Pharma Buffer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bio Pharma Buffer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Bio Pharma Buffer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bio Pharma Buffer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bio Pharma Buffer.
This report presents a comprehensive overview, market shares, and growth opportunities of Bio Pharma Buffer market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Phosphates Type
Acetates Type
TRIS Type
Others
Segmentation by Application:
Research Institution
Pharmaceutical Industry
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Avantor
Alfa Aesar (Thermo Fisher)
Merck
Lonza
Bio-Rad
BD
GE Healthcare
Promega Corporation
Hamilton Company
XZL BIO-TECHNOLOGY
SRL
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bio Pharma Buffer market?
What factors are driving Bio Pharma Buffer market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bio Pharma Buffer market opportunities vary by end market size?
How does Bio Pharma Buffer break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bio Pharma Buffer Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Bio Pharma Buffer by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Bio Pharma Buffer by Country/Region, 2020, 2024 & 2031
2.2 Bio Pharma Buffer Segment by Type
2.2.1 Phosphates Type
2.2.2 Acetates Type
2.2.3 TRIS Type
2.2.4 Others
2.3 Bio Pharma Buffer Sales by Type
2.3.1 Global Bio Pharma Buffer Sales Market Share by Type (2020-2025)
2.3.2 Global Bio Pharma Buffer Revenue and Market Share by Type (2020-2025)
2.3.3 Global Bio Pharma Buffer Sale Price by Type (2020-2025)
2.4 Bio Pharma Buffer Segment by Application
2.4.1 Research Institution
2.4.2 Pharmaceutical Industry
2.4.3 Others
2.5 Bio Pharma Buffer Sales by Application
2.5.1 Global Bio Pharma Buffer Sale Market Share by Application (2020-2025)
2.5.2 Global Bio Pharma Buffer Revenue and Market Share by Application (2020-2025)
2.5.3 Global Bio Pharma Buffer Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Bio Pharma Buffer Breakdown Data by Company
3.1.1 Global Bio Pharma Buffer Annual Sales by Company (2020-2025)
3.1.2 Global Bio Pharma Buffer Sales Market Share by Company (2020-2025)
3.2 Global Bio Pharma Buffer Annual Revenue by Company (2020-2025)
3.2.1 Global Bio Pharma Buffer Revenue by Company (2020-2025)
3.2.2 Global Bio Pharma Buffer Revenue Market Share by Company (2020-2025)
3.3 Global Bio Pharma Buffer Sale Price by Company
3.4 Key Manufacturers Bio Pharma Buffer Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bio Pharma Buffer Product Location Distribution
3.4.2 Players Bio Pharma Buffer Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Bio Pharma Buffer by Geographic Region
4.1 World Historic Bio Pharma Buffer Market Size by Geographic Region (2020-2025)
4.1.1 Global Bio Pharma Buffer Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Bio Pharma Buffer Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Bio Pharma Buffer Market Size by Country/Region (2020-2025)
4.2.1 Global Bio Pharma Buffer Annual Sales by Country/Region (2020-2025)
4.2.2 Global Bio Pharma Buffer Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bio Pharma Buffer Sales Growth
4.4 APAC Bio Pharma Buffer Sales Growth
4.5 Europe Bio Pharma Buffer Sales Growth
4.6 Middle East & Africa Bio Pharma Buffer Sales Growth
5 Americas
5.1 Americas Bio Pharma Buffer Sales by Country
5.1.1 Americas Bio Pharma Buffer Sales by Country (2020-2025)
5.1.2 Americas Bio Pharma Buffer Revenue by Country (2020-2025)
5.2 Americas Bio Pharma Buffer Sales by Type (2020-2025)
5.3 Americas Bio Pharma Buffer Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bio Pharma Buffer Sales by Region
6.1.1 APAC Bio Pharma Buffer Sales by Region (2020-2025)
6.1.2 APAC Bio Pharma Buffer Revenue by Region (2020-2025)
6.2 APAC Bio Pharma Buffer Sales by Type (2020-2025)
6.3 APAC Bio Pharma Buffer Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bio Pharma Buffer by Country
7.1.1 Europe Bio Pharma Buffer Sales by Country (2020-2025)
7.1.2 Europe Bio Pharma Buffer Revenue by Country (2020-2025)
7.2 Europe Bio Pharma Buffer Sales by Type (2020-2025)
7.3 Europe Bio Pharma Buffer Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bio Pharma Buffer by Country
8.1.1 Middle East & Africa Bio Pharma Buffer Sales by Country (2020-2025)
8.1.2 Middle East & Africa Bio Pharma Buffer Revenue by Country (2020-2025)
8.2 Middle East & Africa Bio Pharma Buffer Sales by Type (2020-2025)
8.3 Middle East & Africa Bio Pharma Buffer Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bio Pharma Buffer
10.3 Manufacturing Process Analysis of Bio Pharma Buffer
10.4 Industry Chain Structure of Bio Pharma Buffer
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bio Pharma Buffer Distributors
11.3 Bio Pharma Buffer Customer
12 World Forecast Review for Bio Pharma Buffer by Geographic Region
12.1 Global Bio Pharma Buffer Market Size Forecast by Region
12.1.1 Global Bio Pharma Buffer Forecast by Region (2026-2031)
12.1.2 Global Bio Pharma Buffer Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Bio Pharma Buffer Forecast by Type (2026-2031)
12.7 Global Bio Pharma Buffer Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Avantor
13.1.1 Avantor Company Information
13.1.2 Avantor Bio Pharma Buffer Product Portfolios and Specifications
13.1.3 Avantor Bio Pharma Buffer Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Avantor Main Business Overview
13.1.5 Avantor Latest Developments
13.2 Alfa Aesar (Thermo Fisher)
13.2.1 Alfa Aesar (Thermo Fisher) Company Information
13.2.2 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Product Portfolios and Specifications
13.2.3 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Alfa Aesar (Thermo Fisher) Main Business Overview
13.2.5 Alfa Aesar (Thermo Fisher) Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Bio Pharma Buffer Product Portfolios and Specifications
13.3.3 Merck Bio Pharma Buffer Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Lonza
13.4.1 Lonza Company Information
13.4.2 Lonza Bio Pharma Buffer Product Portfolios and Specifications
13.4.3 Lonza Bio Pharma Buffer Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Lonza Main Business Overview
13.4.5 Lonza Latest Developments
13.5 Bio-Rad
13.5.1 Bio-Rad Company Information
13.5.2 Bio-Rad Bio Pharma Buffer Product Portfolios and Specifications
13.5.3 Bio-Rad Bio Pharma Buffer Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Bio-Rad Main Business Overview
13.5.5 Bio-Rad Latest Developments
13.6 BD
13.6.1 BD Company Information
13.6.2 BD Bio Pharma Buffer Product Portfolios and Specifications
13.6.3 BD Bio Pharma Buffer Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 BD Main Business Overview
13.6.5 BD Latest Developments
13.7 GE Healthcare
13.7.1 GE Healthcare Company Information
13.7.2 GE Healthcare Bio Pharma Buffer Product Portfolios and Specifications
13.7.3 GE Healthcare Bio Pharma Buffer Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 GE Healthcare Main Business Overview
13.7.5 GE Healthcare Latest Developments
13.8 Promega Corporation
13.8.1 Promega Corporation Company Information
13.8.2 Promega Corporation Bio Pharma Buffer Product Portfolios and Specifications
13.8.3 Promega Corporation Bio Pharma Buffer Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Promega Corporation Main Business Overview
13.8.5 Promega Corporation Latest Developments
13.9 Hamilton Company
13.9.1 Hamilton Company Company Information
13.9.2 Hamilton Company Bio Pharma Buffer Product Portfolios and Specifications
13.9.3 Hamilton Company Bio Pharma Buffer Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Hamilton Company Main Business Overview
13.9.5 Hamilton Company Latest Developments
13.10 XZL BIO-TECHNOLOGY
13.10.1 XZL BIO-TECHNOLOGY Company Information
13.10.2 XZL BIO-TECHNOLOGY Bio Pharma Buffer Product Portfolios and Specifications
13.10.3 XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 XZL BIO-TECHNOLOGY Main Business Overview
13.10.5 XZL BIO-TECHNOLOGY Latest Developments
13.11 SRL
13.11.1 SRL Company Information
13.11.2 SRL Bio Pharma Buffer Product Portfolios and Specifications
13.11.3 SRL Bio Pharma Buffer Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 SRL Main Business Overview
13.11.5 SRL Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂